MOUNTAIN VIEW, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter and …
Fourth quarter active customers up 32% and revenue up 33% year over year Fourth quarter net loss was $5.7 million and Adjusted EBITDA was $43.7 million SEATTLE, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY), a trusted provider of …
REDWOOD CITY, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter …
BROOMFIELD, Colo., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Noodles & Company (NASDAQ: NDLS) today announced the appointment of Joe Christina as its President and Chief Operating Officer. A seasoned restaurant executive with more than three decades of …
GAAP Net Income of $0.26 Per Diluted Share for the Fourth Quarter and $0.33 per Diluted Share for the Full Year Normalized FFO of $0.27 Per Diluted Share for the Fourth Quarter and $1.29 per Diluted Share for the Full Year Office Same Store NOI Growth of …
SAN FRANCISCO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- LiveRamp® (NYSE: RAMP), the leading data collaboration platform, today announced that its CEO Scott Howe and CFO Lauren Dillard will present at the Morgan Stanley Technology, Media & Telecom Conference …
REDWOOD CITY, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers, today announced that it will report …
SAN DIEGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- LPL Financial LLC (Nasdaq:LPLA) announced today that financial advisors Shane J. Prill, CFP®, Vance E. Garwood, CFP®, and Grant Garwood, CFP®, have joined LPL Financial’s broker-dealer, Registered Investment …
HOUSTON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (“Amplify” or the “Company”) (NYSE: AMPY) announced today that it will report fourth quarter 2024 financial and operating results after the U.S. financial markets close on March 5, 2025. …
Q4 2024 revenue of $48.1 million Q4 2024 positive Adjusted EBITDA of $5.4 million and GAAP Operating Income of $1.8 million Completed sale of telematics business for $52.7 million in cash Completed convertible debt restructurings with material reductions …
GRI’s common stock is expected to begin trading on a post-split adjusted basis on February 24, 2025 LA JOLLA, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative …
SAN FRANCISCO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that it will report fourth quarter and full …
MENLO PARK, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at TD Cowen's 45th Annual Health Care Conference …
SEATTLE, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and full year ended December 31, 2024. “2024 was a milestone year …
Le bénéfice opérationnel du quatrième trimestre de 160,2 M$ se compare à celui de 198,3 M$ au trimestre correspondant de l’exercice précédent. Le bénéfice net du quatrième trimestre de 88,1 M$ se compare à celui du quatrième trimestre de 2023 de 131,4 M$, …
SAN DIEGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO), an AI-driven innovator of precision antibody therapies, today announced that iBio’s common stock has been approved for listing on the Nasdaq Capital Market and iBio will transfer its …
- Third highest annual cash flow from operations of $1.43 billion - Repurchased record $1.09 billion of common stock in 2024; outstanding shares down 6% - Annual net sales of $13.84 billion with tons sold up 4.0% (same-store tons sold up 1.0%) - Strong …
Fourth quarter operating income of $160.2 million compares to $198.3 million in the same prior year quarter Fourth quarter net income of $88.1 million compares to $131.4 million in Q4 2023, while adjusted net income1 of $101.8 million compares to $147.0 …
Fourth quarter revenue of $160 million and full-year revenue of $637 million Fourth quarter GAAP net income (loss) of ($26) million and full-year GAAP net income (loss) of ($80) million Fourth quarter non-GAAP net income (loss) of ($1) million and full- …
BOSTON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, will participate in an upcoming investor conference. Ido Schoenberg, M.D., Amwell chairman and chief …
01 days 14:21:04
